Literature DB >> 3943429

Clinical features of colorectal carcinoma in cancer family syndrome.

J P Mecklin, H J Järvinen.   

Abstract

A series of 122 patients with colorectal carcinoma belonging to 22 verified Finnish cancer family syndrome kindreds was examined retrospectively. The identification of this hereditary syndrome and the best lines of management were the main concerns of this study. Early presentation (mean, 41 years), the proximal location of the colonic tumors (54 percent in the right colon) and the high frequency of multiplicity (24 percent) were demonstrated clearly. In only 40 percent of patients, however, was a positive family history demonstrable with certainty at the time of diagnosis of the colorectal tumor. A high tendency of second and third colorectal carcinomas to occur was observed with mean annual cumulative rates of 3.2 and 5.4 percent, respectively. It was concluded that identification of the cancer family syndrome remains problematic; for example, with regard to the planning of screening procedures for asymptomatic relatives; until the family history has been clarified carefully. A verified case of colorectal cancer in a cancer family syndrome kindred requires lifelong follow-up examinations of the remaining colon and rectum. Abdominal colectomy is the operation of choice.

Entities:  

Mesh:

Year:  1986        PMID: 3943429     DOI: 10.1007/bf02555012

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  41 in total

1.  The revised Bethesda guidelines: extent of utilization in a university hospital medical center with a cancer genetics program.

Authors:  Aparna Mukherjee; Thomas J McGarrity; Francesca Ruggiero; Walter Koltun; Kevin McKenna; Lisa Poritz; Maria J Baker
Journal:  Hered Cancer Clin Pract       Date:  2010-11-22       Impact factor: 2.857

2.  Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.

Authors:  Andreas Obermair; Danny R Youlden; Joanne P Young; Noralane M Lindor; John A Baron; Polly Newcomb; Susan Parry; John L Hopper; Robert Haile; Mark A Jenkins
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

3.  Familial colorectal cancer: discussion paper.

Authors:  M J Underwood; V W Johnson
Journal:  J R Soc Med       Date:  1992-06       Impact factor: 5.344

4.  Frequency of hereditary nonpolyposis colorectal cancer in southern Alberta.

Authors:  P J Westlake; H E Bryant; S A Huchcroft; L R Sutherland
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

Review 5.  Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry.

Authors:  Jinru Shia; Susanne Holck; Giovanni Depetris; Joel K Greenson; David S Klimstra
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

Review 6.  Lynch syndrome: clinical, pathological, and genetic insights.

Authors:  Ralph Schneider; Claudia Schneider; Matthias Kloor; Alois Fürst; Gabriela Möslein
Journal:  Langenbecks Arch Surg       Date:  2012-02-24       Impact factor: 3.445

7.  Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico.

Authors:  Wilfredo E De Jesus-Monge; Carmen Gonzalez-Keelan; Ronghua Zhao; Stanley R Hamilton; Miguel Rodriguez-Bigas; Marcia Cruz-Correa
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

8.  Inherited colorectal cancer syndromes.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2005-08

9.  Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+.

Authors:  M Goggins; G J Offerhaus; W Hilgers; C A Griffin; M Shekher; D Tang; T A Sohn; C J Yeo; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

Review 10.  Basic concepts for genetic testing in common hereditary colorectal cancer syndromes.

Authors:  Kristina Markey; Lisen Axel; Dennis Ahnen
Journal:  Curr Gastroenterol Rep       Date:  2002-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.